Vivien Wong
Directeur/Membre du Conseil chez CYCLO THERAPEUTICS, INC.
Fortune : 11 375 $ au 30/04/2024
Profil
Vivien Wong is currently an Independent Director at Cyclo Therapeutics, Inc. since 2023 and a Director at Burke Neurological Institute since 2022.
Previously, Dr. Wong worked as the Vice President-Product Development at Progenics Pharmaceuticals, Inc. from 2007 to 2021 and as a Principal at Theritas Pharmaceutical Consultants from 2004 to 2007.
Dr. Wong completed an undergraduate degree at Mississippi University for Women and a doctorate degree at the University of Maryland School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CYCLO THERAPEUTICS INC
0,03% | 01/03/2024 | 8 818 ( 0,03% ) | 11 375 $ | 30/04/2024 |
Postes actifs de Vivien Wong
Sociétés | Poste | Début |
---|---|---|
CYCLO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/08/2023 |
Burke Neurological Institute | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Vivien Wong
Sociétés | Poste | Fin |
---|---|---|
Theritas Pharmaceutical Consultants | Corporate Officer/Principal | 01/09/2007 |
PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2021 |
Formation de Vivien Wong
Mississippi University for Women | Undergraduate Degree |
University of Maryland School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CYCLO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Theritas Pharmaceutical Consultants | |
Burke Neurological Institute |